CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment. Malmeström C, Axelsson M, Lycke J, Zetterberg H, Blennow K, Olsson B J Neuroimmunol. 2014 Feb 13. PMID: 24582001. Abstract CommentRecommendBookmarkWatch